Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:782-783

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Givertz, M. M.
Right arrow Articles by Colucci, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Givertz, M. M.
Right arrow Articles by Colucci, W. S.
Related Collections
Right arrow Contractile function
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Oxidant stress

(Circulation. 2001;103:782.)
© 2001 American Heart Association, Inc.


Editorial

Antioxidants and Myocardial Contractility

Illuminating the "Dark Side" of {beta}-Adrenergic Receptor Activation?

Michael M. Givertz, MD; Douglas B. Sawyer, MD, PhD; Wilson S. Colucci, MD

From the Cardiomyopathy Program and Cardiovascular Section, Boston University Medical Center, and Boston University School of Medicine, Boston, Mass.

Correspondence to Wilson S. Colucci, MD, Cardiovascular Section, Boston University Medical Center, 88 E. Newton Street, Boston, MA 02118. E-mail wilson.colucci@bmc.org


Key Words: Editorials • antioxidants • contractility • receptors, adrenergic, beta • myocardium

Oxidant byproducts, such as superoxide anion (O2) and hydrogen peroxide, are produced as a consequence of normal aerobic metabolism. These molecules, which are highly reactive with other biological molecules, are referred to as reactive oxygen species (ROS). Under normal physiological conditions, ROS production is balanced by an efficient system of antioxidants, molecules that are capable of scavenging ROS and thereby preventing oxidant damage. At the cellular level, naturally occurring enzymatic antioxidants such as superoxide dismutase, glutathione peroxidase, and catalase play an important role in the conversion of ROS to oxygen and water. Several nonenzymatic antioxidants, including the lipid-soluble antioxidants vitamin E and {beta}-carotene and the water-soluble antioxidants vitamin C and glutathione, are also important in scavenging free radicals. Vitamin C in particular protects plasma lipids from peroxidation, scavenges O2, and plays a role in recycling vitamin E.

In pathological states, ROS may be present in relative excess. This shift of the balance in favor of oxidation, termed "oxidative stress," may have detrimental effects on cellular and tissue function. Oxidative stress is thought to contribute to the pathogenesis of a wide variety of disease states, including atherosclerosis1 and cancer, as well as to the normal process of aging. There is increasing evidence that myocardial oxidative stress may contribute to disease progression in heart failure.2 Although the effects of oxidative stress on the myocardium have been investigated in pathological states, very little is known about the role of ROS in the regulation of normal cardiac function. Recently, Ekelund et al3 . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Srivastava, B. Chandrasekar, Y. Gu, J. Luo, T. Hamid, B. G. Hill, and S. D. Prabhu
Downregulation of CuZn-superoxide dismutase contributes to {beta}-adrenergic receptor-mediated oxidative stress in the heart
Cardiovasc Res, June 1, 2007; 74(3): 445 - 455.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens
Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction
J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2368 - 2374.
[Abstract] [Full Text] [PDF]